CHELONI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.134
EU - Europa 1.013
AS - Asia 169
AF - Africa 4
Totale 2.320
Nazione #
US - Stati Uniti d'America 1.130
PL - Polonia 570
RU - Federazione Russa 195
IT - Italia 102
IE - Irlanda 65
CN - Cina 56
SG - Singapore 37
SE - Svezia 35
HK - Hong Kong 30
JO - Giordania 16
IN - India 14
VN - Vietnam 12
DE - Germania 9
GB - Regno Unito 9
FI - Finlandia 8
BE - Belgio 7
AT - Austria 5
CA - Canada 4
CI - Costa d'Avorio 4
FR - Francia 3
ID - Indonesia 3
CH - Svizzera 2
NL - Olanda 2
BD - Bangladesh 1
UA - Ucraina 1
Totale 2.320
Città #
Warsaw 570
Santa Clara 347
Fairfield 103
Chandler 83
Dublin 65
Seattle 64
Ashburn 57
Woodbridge 52
Houston 44
Ann Arbor 39
Cambridge 37
Wilmington 33
Florence 31
Singapore 28
Altamura 18
Beijing 18
Hong Kong 18
Lawrence 17
Princeton 17
Mumbai 13
Buffalo 11
Boston 10
Dong Ket 10
Moscow 9
San Diego 9
Kent 8
Shanghai 8
Brussels 7
Boardman 6
Falls Church 6
Redwood City 6
Rome 6
Turin 6
Renton 5
Vienna 5
Abidjan 4
Cagliari 4
Medford 4
Phoenix 4
Detroit 3
London 3
Malang 3
Munich 3
Toronto 3
Geneva 2
Jacksonville 2
Karlskrona 2
Norwalk 2
Rubano 2
Trumbull 2
Yubileyny 2
Austin 1
Baoding 1
Baotou 1
Brookline 1
Cantagallo 1
Carrara 1
Castel Volturno 1
Castelliri 1
Changsha 1
Contursi 1
Costa Mesa 1
Cuneo 1
Dhaka 1
Fuyang 1
Gallatin 1
Guangzhou 1
Gunzenhausen 1
Harbin 1
Laurel 1
Meizhou 1
Ottawa 1
Parma 1
Pune 1
Redmond 1
Rotterdam 1
Scandicci 1
Shijiazhuang 1
Stevenage 1
Weihai 1
Wuhan 1
Totale 1.841
Nome #
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 289
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 284
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 284
Chronic myeloid leukaemia stem cells are sensitive to the pharmacological inhibition of hypoxia inducible factor-1a 271
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 229
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 146
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 136
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival 127
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 116
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 104
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 98
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 96
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 90
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 83
Totale 2.353
Categoria #
all - tutte 5.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 0 0 40 36 49 39 29 35 6
2020/2021263 18 41 3 39 19 24 12 20 26 38 9 14
2021/2022132 9 10 10 7 9 8 3 10 5 15 20 26
2022/2023322 29 53 21 13 32 49 41 24 48 2 7 3
2023/2024123 7 9 12 9 6 11 10 30 3 4 16 6
2024/2025666 30 71 51 107 276 131 0 0 0 0 0 0
Totale 2.353